Human Muscle Gene Expression Profiles in Young and Old Men (CERA)
To reach the goals of living longer in better medical conditions, many countries reach the same conclusion: new strategies have to be developed to avoid, or at least limit, the effects of age; this requires a better knowledge of the mechanisms of aging. Our project focuses on the loss of muscle mass associated with aging, called sarcopenia. Sarcopenia unavoidably leads to impaired mobility and poor balance, which contributes to loss of functional autonomy and to increased prevalence for severe falls. Skeletal muscle also plays a central role as a reserve for energy and amino acids. Hence, sarcopenia further triggers severe side metabolic effects such as frailty among elderly persons. The precise mechanisms of muscle aging are still mostly unknown, although many theories have been proposed.
The present study aims at better understanding the mechanisms of skeletal muscle loss associated with aging. Using muscle biopsies from young and old subjects, the differential expression profiles of mRNA will be obtained through chips that will evaluate more than 39000 transcripts. On the same samples, proteomic analyses will involve two complementary approaches: (1) bidimensional electrophoresis (2DGE) coupled to mass spectrometry (MALDI-ToF) for dominant proteins; (2) Western-blot (more than 800 antibodies) targeting regulating proteins not detectable using 2DGE. Complementary histological studies (immunohisto-fluorescence, confocal microscopy) will specify the localisation of the major biomarkers in the muscle biopsies.
The results of that research will have applications in the medium term and will lead to nutritional interventions to modulate specific metabolic pathways and improve the quality of life in the elderly.
研究概览
研究类型
注册 (实际的)
联系人和位置
学习地点
-
-
-
Saint-etienne、法国、42000
- CHU de Saint-Etienne
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
取样方法
研究人群
描述
Inclusion Criteria:
- Affiliated or beneficiary of a social security category
- Having signed the inform consent form
- Having signed the genetic consent form
Exclusion Criteria:
- Antiaggregant platelet treatment
- Type 2 diabetes
- Body Mass Index > 25
- Severe renal disease
- CRP > 10
- Abnormal clotting test
- Allergies to local anesthetics
学习计划
研究是如何设计的?
设计细节
队列和干预
团体/队列 |
干预/治疗 |
|---|---|
|
Young
Young men 19-25 years old
|
W1 - Blood test
W2 - Maximal metabolic test using a cycloergometer W3 - Muscular biopsy |
|
Old
old men 70-76 years old, who participate in the PROOF study (NCT 00759304)
|
W1 - Blood test
W2 - Maximal metabolic test using a cycloergometer W3 - Muscular biopsy |
研究衡量的是什么?
主要结果指标
结果测量 |
大体时间 |
|---|---|
|
To identify the differential expression profiles (proteomics, transcriptomics) in skeletal muscle between young and old men
大体时间:During biopsie (W3)
|
During biopsie (W3)
|
次要结果测量
结果测量 |
大体时间 |
|---|---|
|
To specify the localisation of the major biomarkers in the muscle biopsies.
大体时间:During biopsie (W3)
|
During biopsie (W3)
|
|
To compare muscular energy metabolic enzymatic activities between young and old men
大体时间:during biopsie (W3)
|
during biopsie (W3)
|
|
To compare the number of muscular stem cells between young and old men
大体时间:during biopsie (W3)
|
during biopsie (W3)
|
合作者和调查者
合作者
调查人员
- 学习椅:Daniel BECHET, PhD、INRA Clermont-Ferrand
研究记录日期
研究主要日期
学习开始
初级完成 (实际的)
研究完成 (实际的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (估计)
研究记录更新
最后更新发布 (估计)
上次提交的符合 QC 标准的更新
最后验证
更多信息
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.